An Inquiry on the Social and Education Status of Women from Northern Cameroon Suffering Cervical Cancer and the State of Knowledge of their Disease
DOI:
https://doi.org/10.6000/1927-7229.2017.06.04.1Keywords:
Sensitivity, specificity, diagnosis,VIA-VILI, cervical cancer.Abstract
Background: Cervical cancer is a major cause of women death worldwide. The reduction of the mortality and morbidity of this pathology depends on the early detection based on powerful suitable screening methods, that will lead to optimal treatment strategies. However in some rural region of developing countries, it is very difficult to get access to standard screening methods, alternative screening methods, cheaper and easy to handle are then useful.
Objective: The aim of this work was to test the sensitivity and specificity of VIA (Visual inspection with acetic acid) and VILI (Visual inspection with lugol iodine) as screening test of cervical cancer compared to the Pap Smear, evaluating the feasibility in health formation in the North Cameroon region, of implementing epidemiological surveillance of cervical cancer based on early diagnosis using the VIA-VILI association
Method: 309 women age 20 to 62 years were recruited in this study, 307 were included in the statistical analyzes. Each woman was screened for cervical cancer by a conventional Smear and visual inspection with acetic acid 5% and the lugol solution.
Results: We found in our study a prevalence of precancerous lesions of cervix at 12.70%. The risks factors of cervical cancer identified are age, matrimonial status, age of first sexual intercourse and parity. The association of VIA and VILI showed a sensitivity, specificity, positive and negative predictive value respectively about 93.58%; 97.01%; 82.01%, 99.04%.
Conclusion: Compared to PAP Smear, VIA or VILI could be used as an alternative screening methods for cervical cancer in developing countries. However, histology test was recommended to use a « Gold Standard » to evaluate the test accuracy of VIA/VILI because it can be used to diagnose cancer, while PAP smear cannot.
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Mathilde E. Boon, Joke A.M. Dols, Nicodemus Butamanya, Gregor Reid, The Cellient System for Cytohistology to Analyze p16 Positive Dyskeratocytes in Paraffin Sections of HPV-Positive Cervical Scrapes , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- K. Pushkala, P.D. Gupta, Increased Incidence of Breast Cancer Due to Long Exposure of Light , Journal of Analytical Oncology: Vol. 5 No. 4 (2016)
- Vladimir Zaichick, Sofia Zaichick, Sinclair Wynchank, Intracellular Zinc Excess as One of the Main Factors in the Etiology of Prostate Cancer , Journal of Analytical Oncology: Vol. 5 No. 3 (2016)
- Tatiana Levkovich, Theofilos Poutahidis, Kelsey Cappelle, Mark B. Smith, Allison Perrotta, Eric J. Alm , Susan E. Erdman , ‘Hygienic’ Lymphocytes Convey Increased Cancer Risk , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Jason S. Hamilton, Guido F. Verbeck, One-Cell Analysis as a Technique for True Single-Cell Analysis of Organelles in Breast Tumor and Adjacent Normal Tissue to Profile Fatty Acid Composition of Triglyceride Species , Journal of Analytical Oncology: Vol. 5 No. 2 (2016)
- Kenji Ina, Ryuichi Furuta, Takae Kataoka, Sayaka Sugiura, Satoshi Kayukawa, Takayuki Kanamori, Takaki Kikuchi, Megumi Kabeya, Satoshi Hibi , Shu Yuasa , Adverse Effects of Bevacizumab During Treatment for Metastatic Colorectal Cancer , Journal of Analytical Oncology: Vol. 4 No. 1 (2015)
- Abigail Ruiz de Lobera, Aitziber Buqué, Alberto Muñoz, Sergio Carrera, Aintzane Sancho, Itziar Rubio, Eddy I. Gutierrez, Mikel Arruti, Inés Marrodán, Guillermo López-Vivanco, Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Antonieta Salud, Vicente Alonso, Pilar Escudero, Miguel Burillo, Cristina Martín, Fernando Rivera, Alfonso Yubero, Carlos García-Girón, Alberto Muñoz, Phase II Study of Irinotecan in Combination with Capecitabine on a 3-Weekly Schedule as First-Line Chemotherapy for Patients with Metastatic or Locally Advanced Colorectal Cancer , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- Arunima Ghosh, Karlena Lara-Otero, Marston W. Linehan , Maria J. Merino , Can Mutations in the BAP1 Gene be Detected by Immunohisto-chemistry in Hereditary Kidney Cancers? , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Karen Reyes, Guido F. Verbeck, True One Cell Chemical Analysis in Cancer Research: A Review , Journal of Analytical Oncology: Vol. 12 (2023)
You may also start an advanced similarity search for this article.